share_log

藥明康德：董事會會議召開日期

WUXI APPTEC: DATE OF BOARD MEETING

香港交易所 ·  Mar 4 18:02
Summary by Futu AI
药明康德宣布將於2024年3月18日（星期一）召開董事會會議，主要議程為考慮及批准本集團截至2023年12月31日止年度全年業績，並討論建議之末期股息。會議將由董事長李革博士主持，並處理其他事項。董事會成員包括執行董事、非執行董事及獨立非執行董事。
药明康德宣布將於2024年3月18日（星期一）召開董事會會議，主要議程為考慮及批准本集團截至2023年12月31日止年度全年業績，並討論建議之末期股息。會議將由董事長李革博士主持，並處理其他事項。董事會成員包括執行董事、非執行董事及獨立非執行董事。
Ming Kand Pharmaceuticals announces that a Board Meeting will be held on Monday, March 18, 2024. The main agenda is to consider and approve the Group's annual results for the year ended 31 December 2023 and to discuss the proposed final dividend. The meeting will be chaired by Dr. Li Keung, Chairman, and will address other matters. Board members include executive directors, non-executive directors and independent non-executive directors.
Ming Kand Pharmaceuticals announces that a Board Meeting will be held on Monday, March 18, 2024. The main agenda is to consider and approve the Group's annual results for the year ended 31 December 2023 and to discuss the proposed final dividend. The meeting will be chaired by Dr. Li Keung, Chairman, and will address other matters. Board members include executive directors, non-executive directors and independent non-executive directors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.